114 results on '"Batista, Alzir A."'
Search Results
2. Phenanthroline and phenyl carboxylate mixed ligand copper complexes in developing drugs to treat cancer
3. New Ru(II)-p-cymene compounds bearing indomethacin and indomethacin-pyridineamide ligands: synthesis, characterization, computational studies and investigation of their interactions with the Human Serum Albumin
4. Palladium(II) and platinum(II) thiophene-based thiosemicarbazones: Synthesis, properties, and anticancer studies
5. Cobalt(III)-py2en systems as potential carriers of β-ketoester-based ligands
6. An overview on the anticancer activity of Ru(II)/acylthiourea complexes
7. Cytotoxic activity of Ru(II)/DPEPhos/N,S-mercapto complexes (DPEPhos = bis-[(2-diphenylphosphino)phenyl]ether)
8. Molecular structure of Ru(II)/diphosphine/4,6-dimethyl-2-pyrimidinethiol complexes: A combined experimental and density functional theory study
9. Gallium and indium complexes with isoniazid-derived ligands: Interaction with biomolecules and biological activity against cancer cells and Mycobacterium tuberculosis
10. New ruthenium complexes containing salicylic acid and derivatives induce triple-negative tumor cell death via the intrinsic apoptotic pathway
11. Novel Ru(II)-bipyridine/phenanthroline-lapachol complexes as potential anti-cancer agents
12. Cytotoxic and antiparasitic activities of diphosphine-metal complexes of group 10 containing acylthiourea as ligands
13. Gold(III) heteroleptic complexes with SNS-thiosemicarbazonate ligands as cytotoxic agents: Experimental and computational insights into the mechanism of action
14. Ru(II)/amino acid complexes inhibit the progression of breast cancer cells through multiple mechanism-induced apoptosis
15. Anti-melanoma effect of ruthenium(II)-diphosphine complexes containing naphthoquinone ligand
16. Scavenging capacity and cytotoxicity of new Ru(II)-diphosphine/α-amino acid complexes
17. Ruthenium complexes show promise when submitted to toxicological safety tests using alternative methodologies
18. Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug
19. Synthesis and characterization of η6-p-cymene ruthenium(II) complexes containing alkyl- and methoxy-substituted triarylphosphines
20. Cytotoxicity of ruthenium-N,N-disubstituted-N′-acylthioureas complexes
21. Antitumor activity of Pd(II) complexes with N,S or O,S coordination modes of acylthiourea ligands
22. Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid
23. Synthesis and structural characterization of a series of ternary copper(II)-L-dipeptide-neocuproine complexes. Study of their cytotoxicity against cancer cells including MDA-MB-231, triple negative breast cancer cells
24. cis-bis(N-benzoyl-N′,N′-dibenzylthioureido)platinum(II): Synthesis, molecular structure and its interaction with human and bovine serum albumin
25. Ru(II) complexes containing uracil nucleobase analogs with cytotoxicity against tumor cells
26. A simple alternative to prodrug: The hydrochloride salt monohydrate of the prostate anticancer drug abiraterone
27. Ru(II)/N-N/PPh3 complexes as potential anticancer agents against MDA-MB-231 cancer cells (N-N = diimine or diamine)
28. Acute toxic effects of ruthenium (II)/amino acid/diphosphine complexes on Swiss mice and zebrafish embryos
29. Hydrolysis reaction promotes changes in coordination mode of Ru(II)/acylthiourea organometallic complexes with cytotoxicity against human lung tumor cell lines
30. The trans-[Ru(PPh3)2(N,N-dimethyl-N′-thiophenylthioureato-k2O,S)(bipy)]PF6 complex has pro-apoptotic effects on triple negative breast cancer cells and presents low toxicity in vivo
31. Cytotoxic activity and structural features of Ru(II)/phosphine/amino acid complexes
32. Phosphine/diimine ruthenium complexes with Cl−, CO, NO+, NO2−, NO3− and pyridine ligands: Pro-apoptotic activity on triple-negative breast cancer cells and DNA/HSA interactions
33. Synthesis, characterization and reactivity of halides/pseudohalides and their complexes containing ruthenium II in the hydrogenation of cyclohexene
34. Selective Ru(II)/lawsone complexes inhibiting tumor cell growth by apoptosis
35. Palladium(II)/N,N-disubstituted-N′-acylthioureas complexes as anti-Mycobacterium tuberculosis and anti-Trypanosoma cruzi agents
36. Ruthenium(II)/triphenylphosphine complexes: An effective way to improve the cytotoxicity of lapachol
37. Propyl gallate metal complexes: Circular dichroism, BSA-binding, antioxidant and cytotoxic activity
38. Heteroleptic tris-chelate ruthenium(II) complexes of N,N-disubstituted-N′-acylthioureas: Synthesis, structural studies, cytotoxic activity and confocal microscopy studies
39. Understanding the conformational changes and molecular structure of furoyl thioureas upon substitution
40. Hydroformylation-hydrogenation and hydroformylation-acetalization reactions catalyzed by ruthenium complexes
41. In vitro and in vivo antitumor activity of a novel carbonyl ruthenium compound, the ct-[RuCl(CO)(dppb)(bipy)]PF6[dppb = 1,4-bis(diphenylphosphine)butane and bipy = 2,2′-bipyridine]
42. Ru(II)/clotrimazole/diphenylphosphine/bipyridine complexes: Interaction with DNA, BSA and biological potential against tumor cell lines and Mycobacterium tuberculosis
43. Experimental and theoretical studies of copper complexes with isomeric dipeptides as novel candidates against breast cancer
44. Ruthenium(III)/phosphine/pyridine complexes applied in the hydrogenation reactions of polar and apolar double bonds
45. Ruthenium(II) complexes of 1,3-thiazolidine-2-thione: Cytotoxicity against tumor cells and anti-Trypanosoma cruzi activity enhanced upon combination with benznidazole
46. A ruthenium(II) complex with the propionate ion: Synthesis, characterization and cytotoxic activity
47. Cytotoxicity of Ru(II) piano–stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA
48. Ru(II)-based complexes with N-(acyl)-N′,N′-(disubstituted)thiourea ligands: Synthesis, characterization, BSA- and DNA-binding studies of new cytotoxic agents against lung and prostate tumour cells
49. Cis-[RuCl(BzCN)(N–N)(P–P)]PF6 complexes: Synthesis and in vitro antitumor activity: (BzCN = benzonitrile; N–N = 2,2′-bipyridine; 1,10-phenanthroline; P–P = 1,4-bis(diphenylphosphino) butane, 1,2-bis(diphenylphosphino)ethane, or 1,1′-(diphenylphosphino)ferrocene)
50. Crystal structure and catalytic activity of ruthenium (II)/dithiocarbamate complexes in the epoxidation of cyclooctene
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.